Time-lapse mapping of cortical changes in schizophrenia with different treatments.

Using time-lapse maps, we visualized the dynamics of schizophrenia progression, revealing spreading cortical changes that depend on the type of antipsychotic treatment. Dynamic, 4-dimensional models of disease progression were created from 4 repeated high-resolution brain magnetic resonance imaging scans of 36 first-episode schizophrenia patients (30 men/6 women; mean age: 24.2 +/- 5.1 SD years) randomized to haloperidol (HAL) (n = 15) or olanzapine (OLZ) treatment (n = 21), imaged at baseline, 3, 6, and 12 months (144 scans). Based on surface-based cortical models and point-by-point measures of gray matter volume, we generated time-lapse maps for each treatment. Disease trajectories differed for atypical versus typical neuroleptic drugs. A rapidly advancing parietal-to-frontal deficit trajectory, in HAL-treated patients, mirrored normal cortical maturation but greatly intensified. The disease trajectory advanced even after symptom normalization, involving the frontal cortex within 12 months with typical drug treatment. Areas with fastest tissue loss shifted anteriorly in the first year of psychosis. This trajectory was not seen with OLZ. Whether this association reflects either reduced neurotoxicity or neuroprotection cannot be addressed with neuroimaging; changes may relate to glial rather than neural components. These maps revise current models of schizophrenia progression; due to power limitations, the findings require confirmation in a sample large enough to model group x time interactions.

[1]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.

[2]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[3]  L. DeLisi,et al.  Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients , 1987, Biological Psychiatry.

[4]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[5]  S. Anderson,et al.  Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. , 1994, Journal of psychiatric research.

[6]  D. Louis Collins,et al.  Automatic 3‐D model‐based neuroanatomical segmentation , 1995 .

[7]  Manzar Ashtari,et al.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.

[8]  J. Coyle,et al.  Tardive dyskinesia and substrates of energy metabolism in CSF. , 1995, The American journal of psychiatry.

[9]  Alan C. Evans,et al.  Automatic 3D Regional MRI Segmentation and Statistical Probability Anatomy Maps , 1996 .

[10]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[11]  L. DeLisi,et al.  Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia , 1997, Psychiatry Research: Neuroimaging.

[12]  E. Leibenluft,et al.  Agreement between face-to-face and telephone-administered mood ratings in patients with rapid cycling bipolar disorder , 1997, Psychiatry Research.

[13]  J. Bloomquist,et al.  Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia , 1998, Brain Research.

[14]  Alan C. Evans,et al.  A method for identifying geometrically simple surfaces from three-dimensional images , 1998 .

[15]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[16]  B. Woods Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. , 1998, The American journal of psychiatry.

[17]  Jeffrey A Lieberman,et al.  Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective , 1999, Biological Psychiatry.

[18]  P. Goldman-Rakic,et al.  Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure , 1999, Biological Psychiatry.

[19]  L. Grossman,et al.  Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms , 2000, British Journal of Psychiatry.

[20]  S. Kapur,et al.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. , 2000, Journal of psychiatry & neuroscience : JPN.

[21]  R. Hoffman,et al.  Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.

[22]  G. Duncan,et al.  Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. , 2000, The Journal of pharmacology and experimental therapeutics.

[23]  J. Lieberman,et al.  The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches , 2001, Biological Psychiatry.

[24]  J. Rapoport,et al.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K O Lim,et al.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[26]  S. Heckers,et al.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.

[27]  R. Leahy,et al.  Magnetic Resonance Image Tissue Classification Using a Partial Volume Model , 2001, NeuroImage.

[28]  J. Kane,et al.  Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. , 2002, The Journal of clinical psychiatry.

[29]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[30]  Lorena Hsu,et al.  Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[31]  K. Nylen,et al.  Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration , 2002, Brain Research.

[32]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[33]  Tyrone D. Cannon,et al.  Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. , 2003, Schizophrenia bulletin.

[34]  Jim Mintz,et al.  Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study , 2003, Biological Psychiatry.

[35]  J. Lieberman,et al.  Olanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents , 2003, Neuropsychopharmacology.

[36]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[37]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[38]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[39]  Suzanne E. Welcome,et al.  Mapping cortical change across the human life span , 2003, Nature Neuroscience.

[40]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[41]  J. Lieberman,et al.  Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. , 2003, The American journal of psychiatry.

[42]  Nancy C. Andreasen,et al.  Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent , 2004, Schizophrenia Research.

[43]  Kiralee M. Hayashi,et al.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia , 2004, NeuroImage.

[44]  J. Quevedo,et al.  Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain , 2004, Neuroscience Letters.

[45]  A. Deutch,et al.  Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat , 2004, Neuropsychopharmacology.

[46]  Thomas F. Nugent,et al.  Dynamic mapping of human cortical development during childhood through early adulthood. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Lieberman,et al.  Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. , 2004, The American journal of psychiatry.

[48]  V. Parikh,et al.  Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol , 2004, Neuroscience Letters.

[49]  A. Peters,et al.  Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. , 2004, Cerebral cortex.

[50]  Tyrone D. Cannon,et al.  Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. , 2005, Archives of general psychiatry.

[51]  V. Molina Structural effects of atypical antipsychotics: Implications for the meaning of cortical volume deficit in schizophrenia , 2005 .

[52]  Kiralee M. Hayashi,et al.  Abnormal Cortical Complexity and Thickness Profiles Mapped in Williams Syndrome , 2005, The Journal of Neuroscience.

[53]  Marek Kubicki,et al.  Evidence for white matter abnormalities in schizophrenia , 2005, Current opinion in psychiatry.

[54]  Paul J. Harrison Neuropathology of schizophrenia , 2005 .

[55]  Kiralee M. Hayashi,et al.  Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[57]  R. Woods,et al.  Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia , 2005, Biological Psychiatry.

[58]  J. Potash,et al.  Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders , 2005, International review of psychiatry.

[59]  John Suckling,et al.  Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study , 2005, Neuropsychopharmacology.

[60]  Manzar Ashtari,et al.  White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. , 2005, The American journal of psychiatry.

[61]  Eve C. Johnstone,et al.  Grey matter changes over time in high risk subjects developing schizophrenia , 2005, NeuroImage.

[62]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[63]  R. S. Kahn,et al.  Brain volume changes in the first year of illness and 5-year outcome of schizophrenia , 2006, British Journal of Psychiatry.

[64]  John H. Gilmore,et al.  Apoptotic mechanisms and the synaptic pathology of schizophrenia , 2006, Schizophrenia Research.

[65]  P. Renshaw,et al.  Regional cerebral cortical thinning in bipolar disorder. , 2006, Bipolar disorders.

[66]  Norbert Schuff,et al.  Longitudinal stability of MRI for mapping brain change using tensor-based morphometry , 2006, NeuroImage.

[67]  Adrian Preda,et al.  Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. , 2006, The American journal of psychiatry.

[68]  Kiralee M. Hayashi,et al.  Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. , 2006, Archives of general psychiatry.

[69]  Michael F. Green,et al.  Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. , 2007, Archives of general psychiatry.

[70]  J. Lieberman Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. , 2007, The Journal of clinical psychiatry.

[71]  Arthur W Toga,et al.  Relationships between IQ and regional cortical gray matter thickness in healthy adults. , 2007, Cerebral cortex.

[72]  Paul M. Thompson,et al.  3D pattern of brain abnormalities in Williams syndrome visualized using tensor-based morphometry , 2007, NeuroImage.

[73]  Agatha D. Lee,et al.  Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. , 2007, Cerebral cortex.

[74]  Kiralee M. Hayashi,et al.  Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder , 2007, Biological Psychiatry.

[75]  R. Kahn,et al.  Progressive brain changes in schizophrenia. , 2007, Schizophrenia bulletin.

[76]  Hui-Dong Wang,et al.  Dopamine Depletion of the Prefrontal Cortex Induces Dendritic Spine Loss: Reversal by Atypical Antipsychotic Drug Treatment , 2008, Neuropsychopharmacology.

[77]  Eugene S. Edgington,et al.  Randomization Tests , 2011, International Encyclopedia of Statistical Science.